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Abstract
Purpose Conventional meshes for hernia repair and
abdominal wall reinforcement are usually made from
polypropylene, polyester or other synthetic plastic materi-
als known to promote foreign body reactions and a state of
chronic inflammation that may lead to long-term compli-
cations. A novel approach is to use long-term resorbable
implants like TIGR Matrix Surgical Mesh. Preclinical
studies have shown that this mesh maintains mechanical
integrity beyond the point in time where newly formed
tissue is capable of carrying the abdominal loads.
Methods This was a first-in-man, prospective, pilot study
performed during 2009, at two sites in Sweden. Forty
patients with primary inguinal hernias were enrolled for
Lichtenstein repair using TIGR Matrix Surgical Mesh.
The primary endpoint was safety as assessed by monitoring
the incidence of adverse events and serious adverse events
(SAEs) both related and unrelated to the mesh. The sec-
ondary endpoint was pain or discomfort. Visual Analogue
Scale (VAS) 0–10 and Inguinal Pain Questionnaire were
used for scoring pain and discomfort. Included patients
have been followed for 36 months using ultrasound in
combination with clinical examination.
Results All patients followed a normal early postopera-
tive course. After 12 months no SAEs were reported. None
of the patients with an isolated lateral inguinal hernia (LIH)
had developed a recurrence but 4 (44 %) with medial and 4
(33 %) with combined hernias had recurred at 36-month
follow-up. After 3-year follow-up none of the patients with
LIH reported pain in the VAS-form and none of those
patients could feel the sensation of a mesh in their groin. In
the total study population 5 (16 %) patients experienced
chronic pain in the form of mild sporadic pain and 3
(9.7 %) patients could feel the sensation of a mesh in their
groin.
Conclusion The use of a synthetic long-term resorbable
mesh (TIGR Matrix Surgical Mesh) in Lichtenstein repair
was found to be safe, without recurrences, and promising
regarding pain/discomfort at 3-year follow-up in patients
with LIH. However, patients with medial and combined
inguinal hernias had high recurrence rates.
Keywords Hernia  Absorbable implant  Surgical mesh 
Recurrence  Indirect inguinal hernia  Chronic pain
Introduction
Inguinal hernia repair using prosthetic reinforcing meshes
has led to reduced recurrence rates since the standardiza-
tion of surgical techniques in the early 1990s. With the
increased success in terms of low recurrence rates, the
focus has shifted towards other complications following
surgery, mainly chronic postoperative pain and discomfort.
Pain complications are reported in varying degrees ranging
from 0 to above 40 % [1]. It can be hypothesized that the
mesh itself contributes to the postoperative pain since its
presence gives rise to a chronic inflammatory reaction
and a foreign body response. Adverse events (AEs)
involving mesh products have been described in the clini-
cal literature [2].
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It has been suggested that meshes with reduced amount
of material could be beneficial in terms of pain and dis-
comfort [3], and some aspects of pain perception have been
shown to be reduced when so-called light-weight meshes
are being used [4–6]. With the long-term objective of
reducing pain and discomfort further, a next step would be
to investigate whether a completely resorbable mesh can
improve results.
In order for this approach to be considered, it is of
course imperative that the already low recurrence rates
remain, and that no additional patient risks are introduced.
A new synthetic resorbable mesh with slow degradation
rate has recently been developed and in preclinical trials
with 3-year follow-up it has shown satisfactory results for
treatment of full-thickness abdominal wall defects in sheep,
[7] with restoration of full-thickness connective tissue and
no defect recurrences. The purpose of this study is to take
the next step and establish first-in-man safety data for the
use of the synthetic long-term resorbable mesh for inguinal
hernia repair using the Lichtenstein technique.
Methods
Approval to start the study was given by the Swedish
Medical Products Agency and the regional ethics com-
mittee in February 2009. Between April and December
2009, 40 male patients aged 18 years or older with primary
unilateral inguinal hernias were enrolled at two different
sites in Sweden. Patients were excluded if they had stran-
gulated or irreducible hernias or if they were unwilling or
unable to give informed consent to participate in the study.
Since pain was one of the outcome measurements of the
study, patients were excluded if they had preexisting pain
conditions unrelated to the hernia.
Mesh characteristics
The mesh used for the study was TIGR Matrix Surgical
Mesh (Novus Scientific Pte Ltd., Singapore), a macropo-
rous multifilament knitted construction of two different
resorbable fibers: a fast and a slow-degrading synthetic co-
polymer. The first fiber resorbs within the initial 4 months
following implantation and the mesh becomes softer and
more flexible. The second fiber is completely resorbed after
*3 years due to degradation by hydrolysis [7].
The initial burst strength of the mesh implant as mea-
sured according to American Society for Testing and
Materials D3787 is above 300 N. This strength is compa-
rable to existing commercially available products that
range between 170 and 750 N. More than 50 % of the
initial mechanical strength of the mesh, above theoretical
and measured values of the highest forces acting on the
abdominal wall [8, 9], is maintained during the first
26 weeks, after that the mechanical strength of the mesh is
gradually lost [7].
Surgery and follow-up methods
Included patients underwent open mesh repair using the
Lichtenstein technique [10]; this means reduction of the
lateral sac with a rapidly absorbable suture in lateral
inguinal hernias (LIH), reduction and/or inversion of the
medial sac with rapidly absorbable sutures on the fascia
transversalis if considered necessary in medial inguinal
hernias (MIH). The mesh was fixed to the tissue with
continuous polypropylene sutures to the inguinal ligament
and one single suture to the aponeurotic tissue over the
pubic bone and the internal oblique aponeurosis. All sur-
gical procedures were performed by three experienced staff
surgeons at Sahlgrenska University Hospital and Halland’s
Hospital in Sweden. Operative details recorded included
hernia type and size, incision length, whether the nerves
were identified and preserved or divided, and any devia-
tions from the Lichtenstein technique. Preoperative data
and operation details correspond with what is found in the
general population as published in the Swedish Hernia
Register [11].
Adverse events, such as wound infection, hematoma,
seroma, pain, among others and serious adverse event
(SAEs), according to the FDA definition [12], were docu-
mented during surgery and throughout the follow-up. The
monitoring included visits to the clinic at 14 days, 6, 12
and 36 months postoperatively, as well as telephone
interviews by a research nurse at 1, 3 and 24 months. At
the 36-month follow-up an ultrasound was performed by a
radiologist experienced in hernia diagnostics, in order to
identify clinically undiagnosed recurrences. All patients
will continue to be monitored beyond the 3-year follow-up
with respect to recurrences and other complications,
through the Swedish Hernia Register.
Postoperative pain was measured using two validated
methods frequently used in hernia repair research studies:
an ungraded Visual Analogue Scale (VAS) ranging 0 (no
pain)–10 (worst possible pain) and the Inguinal Pain
Questionnaire (IPQ) [13–15].
The VAS was filled out before surgery and during the
follow-up period to elucidate the pain experienced during
rest, coughing, rising from lying to sitting, climbing one
step in a flight of stairs and taking a 30 m indoor walk.
A symptom questionnaire and an analgesics diary were
used to assess other factors related to the patients’ quality
of life following surgery.
The IPQ-form was only filled in at the 36-month follow-
up as a way to improve the evaluation of the pain and its
effect on patients’ daily activities at this endpoint.
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The date when the patients returned to paid work (if
applicable) after surgery was also recorded.
In patients who were re-operated because of recurrence,
a fine-needle biopsy was taken from the fascia transversalis
and from the aponeurosis of the obliquus internus muscle.
These patients were subsequently excluded from the fol-
low-up program because a nonabsorbable mesh was
implanted and the new surgery would interfere with the
results in terms of pain from the long-term resorbable
mesh.
Statistics
All statistical analyses were performed using the SAS
System (SAS Institute Inc., Cary, NC, USA). Continuous
data were summarized using descriptive statistics.
Results
Forty patients gave informed consent to participate in the
study. One patient was deemed unsuitable for surgery by
the investigator, and one patient was excluded 6 months
after surgery due to another disease that interfered with
follow-up. Three additional patients failed to come to the
36-month follow-up control.
Thirty-eight patients completed the 12-month follow-up.
Thirty-five patients completed the 3-year follow-up, of
which four patients, re-operated for recurrence, were
excluded from filling in pain forms and undergoing ultra-
sound examination. Two patients with recurrences but not
re-operated at this time were included in the VAS and IPQ
report (Fig. 1).
Preoperative data and operation details for the 39
patients who underwent surgery are shown in Table 1.
All patients followed a normal early postoperative
course as confirmed by the 14-day visit to the clinic and the
1-month telephone follow-up. The mean time to return to
work was 12 days (1–35).
No SAEs were recorded during this period. AEs unlikely
related to the mesh were ear pain, ear infection, viral
encephalitis, muscular weakness, prostate cancer and uri-
nary retention/dysuria, one patient with each diagnosis. No
seroma, wound infection or hematoma needing follow-up
or treatment was found.
Recurrence
No patient with an isolated LIH had developed a hernia
recurrence at the 3-year follow-up. All recurrences have been
found in either the MIH group or in the combined inguinal
hernia (CIH) group, four patients in each group (Table 2).
Enrolled
n=40
1 patient was judged 
unsuitable for surgery and 
excluded by surgeon  
Lichtenstein with TIGR® Matrix Surgical Mesh
n=39
6 and 12- month follow up
n= 38




Lost to follow-up 
n=3
36-month follow-up with ultrasound 
and VAS/ IPQ-form
n=31
Excluded from ultrasound and
VAS/IPQ form due to surgery for 
recurrence         n=4                
Fig. 1 Diagram for enrolment
and follow-up of patients of the
study
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During the follow-up period in total 8 (22.8 %) patients
were diagnosed with recurrences: one patient before the
12-month follow-up, three patients before the 24-month
follow-up and four patients at 36-month follow-up. Of the
patients with recurrences, five have been re-operated with
laparoscopic technique and one with a Lichtenstein
approach. Two patients have so far declined a re-operation.
The anatomical location of the recurrences as confirmed
by re-operation or ultrasound has also been medial in 7
(87 %) patients and remains unclear by ultrasound in 1
(13 %) patient which had primarily a CIH and declined a
re-operation. All recurrences found by physical examina-
tion were confirmed by ultrasound.
No remnants of foreign material were found using fine-
needle biopsies on any of the five laparoscopically re-
operated patients, one 24 months and four 36 months after
the primary surgery. No fine-needle biopsy was taken on
the open re-operated patient because patient’s consent had
not been obtained.
Chronic postoperative pain
The pain experienced diminished over time as compared to
before surgery: no patients experienced any severe pain,
defined as VAS[5 in the VAS-form, or pain that interfered
with activities in the IPQ-form, other than before surgery.
At the 3-year follow-up all patients with isolated LIH
reported no pain in the VAS-form and only one patient
(7 %) with LIH experienced mild pain in the IPQ-form, but
this pain did not affect daily activities.
Of the study population, 10 (26.3 %) patients reported
mild pain (VAS \3) at 3 months, which declined to 8
(21.1 %) at 6 months, and 5 (13.5 %) after 1 year.
At the 3-year follow-up, chronic pain [15], defined as
the experience of any pain (VAS[0), was reported only by
2 (8 %) patients in the study population without recurrence.
In the total study population excluding re-operated patients
but including patients with recurrence, chronic pain was
reported by 4 (12.9 %) patients in the VAS-form (VAS[0)
and 5 (16 %) patients in the IPQ-form. No relation between
identification of the nerves and chronic pain was found.
At 3-year follow-up no patients with isolated LIH, could
feel a mesh sensation in their groin and only 3 (9.7 %)
patients had such sensation in the total study population.
The comprehensive results from the VAS questionnaires are
presented in Tables 3 and 4 and the results from the IPQ-form
in Table 5. Other assessments related to quality of life that were
part of the symptoms questionnaires are shown in Table 6.
Discussion
Resorbable meshes
Inguinal hernia repair is one of the more commonly per-
formed procedures in general surgery and the introduction
Table 1 Pre- and per-operative data (n = 39)
Age (years)a 59.7 (40.79)
Weight (kg)a 80.8 (70.96)













Operating time (min)b 51 (16)









\ 1.5 cm 0 (0.0)
1.5–3 cm 24 (61.5)
[ 3 cm 15 (38.5)
Values in parenthesis are percentages unless indicated otherwise
a Values are mean (min, max)
b Values are mean (std)
Table 2 Type of primary hernia defect and type of recurrences after
3 years (n = 35)
Lateral Medial Combined
Primary operation 14 (40) 9 (25.7) 12 (34.3)
Total recurrences 0 (0.0) 4 (44.4) 4(33.3)
Type of recurrence Medial 4 (100 %) Medial 3 (75 %)
Unclear 1 (25 %)
Values in parenthesis are percentages
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of prosthetic meshes has led to a drastic improvement in
recurrence rates. Pain and discomfort remain an unsolved
problem, however, and it has been shown that a reduction
of the amount of permanent material implanted can
improve the situation [4–6]. This study has been performed
using a long-term resorbable synthetic mesh, with the
primary objective of showing that this approach is feasible
and acceptable from a patient safety point of view. Con-
cerns related to the use of resorbable materials have been
raised on several occasions, but mostly in the context of
quickly resorbing materials such as glycolide sutures and
meshes or polyglycolic acid/trimethylene carbonate mesh
that completely lose their mechanical integrity within
weeks [17–19].
The concept of using a long-term resorbable mesh for
hernia repair differs from previous experiences as it allows
for normal wound healing mechanisms to act before the
mesh loses its mechanical contribution, given that the mesh
is accommodating enough to transfer loads to the new
tissue, thereby mechanically stimulating collagen remod-
eling [20, 21]. Furthermore, the now widespread use of
prostheses of biological origin, of which some are enzy-
matically degraded in a relatively short time, has shown
that soft tissue defects may sometimes only need rein-
forcement and restoration, not permanent repair, and that
native connective tissue can be strong enough to carry
bodily loads once the reinforcing implant has been degra-
ded [22, 23].
Recurrences in patients with LIH
Recurrence rates will unavoidably be in focus when
degradable materials are discussed in the context of
abdominal wall surgery, especially in the light of the evi-
dence of hernias being caused by an altered collagen
metabolism or alteration of tissue remodeling [18, 24].
Our results show large differences between recurrences
of lateral and MIH, in our case no recurrences in LIH but a
high recurrence rate in MIH, when using a long-term
degradable mesh, as assessed at 3-year follow-up.
We performed a classical Lichtenstein technique
meaning that we used a nonabsorbable polypropylene
suture to fix the mesh, but none of those stitches was
positioned so that they closed the hernia defect. The
reduction of the lateral sac was made with a rapidly
absorbable suture. Previous publications have shown that
this suture may be enough to prevent hernia recurrences in
children but not in adults [25, 26].
Taking these facts into account, it is more probable that
the absence of recurrence in patients with LIH depend on
the implant utilized in our study.
A recently published pilot study showed a high recur-
rence rate 3 years after the primary operation in both LIH
and MIH using a short-term absorbable mesh made of
polyglycolic acid/trimethylene carbonate [19]. The differ-
ences in the rate of recurrences in LIH between that study









At rest 1.0 (2.5) 0.1 (0.1) 0.1 (0.1)
On coughing 1.5 (4.0) 0.1 (0.1) 0.1 (0.8)
When rising from lying
to sitting
2.2 (5.5) 0.2 (0.2) 0.1 (0.2)
When climbing one step
in a flight of stairs
1.3 (2.9) 0.1 (0.1) 0.1 (0.1)
When taking a 30 m indoor
walk
1.6 (3.3) 0.1 (0.1) 0.1 (0.6)
Overall (calculated as mean
of the 5 scores above)
1.5 (0.2) 0.1(0.0) 0.1 (0.0)
Values are mean (std)
Table 4 Number of patients without and with pain as measured using
VAS at the 3-year follow-up (n = 31)






At rest 31 0 0 0
On coughing 31 0 0 0
When rising from lying to
sitting
31 0 0 0
When climbing one step in a
flight of stairs
27 3 1 0
When taking a 30 m indoor
walk
31 0 0 0
Total no. of patients with any
pain at anytime
27 3 1 0








No pain 5 (16.1) 27 (87.0) 26 (83.8)
Can easily be ignored 5 (16.1) 3 (9.6) 4 (12.9)
Cannot be ignored, no
interference with daily
activities
7 (22.5) 1 (3.2) 1 (3.2)
Interference with concentration
on chores and daily activities
8 (25.8) 0 (0.0) 0 (0.0)
Interference with most activities 5 (16.1) 0 (0.0) 0 (0.0)
Need bed rest because of pain 0 (0.0) 0 (0.0) 0 (0.0)
Need prompt medical advice
because of pain
1 (3.2) 0 (0.0) 0 (0.0)
Values are number of patients with percentages in parenthesis
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and the present study could be explained by the differences
in the time of resorption for the different meshes. The
polyglycolic acid/trimethylene carbonate mesh loses more
than 50 % of the initial mechanical strength after 6 weeks
[19] in contrast to TIGR Matrix Surgical Mesh which
starts losing mechanical strength after about 6 months [7].
Tissue remodeling with newly formed collagen filaments
and developing enough strength to replace the implant can
take time, and that may be the reason why the quickly
resorbable mesh failed.
The role of long-term resorbable meshes in LIH repair
cannot be elucidated from this study because of the limited
number of patients and the study was not designed for
subgroup analysis, but so far we have not found any
recurrences in patients operated upon for LIH in this study.
Recurrences in patients with MIH
The present study has found that the anatomical location
for the hernia recurrence was almost exclusively in the
fascia transversalis (87 %), also recurrence as an MIH. The
national rate of recurrence in the Swedish Hernia Register
is 4.6 % for MIH and 2.4 % for LIH [11]. It suggests that
the surprisingly high rates of recurrences in the fascia
transversalis found in this study did not come only from
aleatoric factors.
A possible explanation for the higher recurrence rate
after MIH operations when using a long-term resorbable
mesh could be that the pathophysiology differs much more
between MIH and LIH than what was previously thought.
In other words, patients with MIH possibly have a more
marked alteration of their tissue remodeling, thereby being
unable to form a scar tissue strong enough to replace the
mesh during the course of its resorption.
Other studies have shown the same pattern: Rodrigues
et al. [27] showed lower collagen content per milligram of
fascia transversalis in MIH patients than in LIH patients.
Bellon et al. [28] demonstrated increased levels of factors
that help degradation of collagen as matrix metallopro-
teinase 2 (MMP-2) and transforming growth factor B1
expression in fascia transversalis of MIH patients compared
with patients with LIH or control patients. Abci et al. [29]
found lower expression of the inhibitor of MMP-2: tissue
inhibitor of metalloproteinase-2 in fascia transversalis in
patients with MIH compared with those with LIH or control
patients and Kayaoglu et al. [30] showed lower levels of
copper, a cofactor of an enzyme in collagen tissue metab-
olism, in plasma and in the hernia sac of MIH patients in
comparison to LIH patients. A recently published article by
Vestergaard et al. [31] found that cumulative exposure to
daily heavy lifting activities was associated with the risk of
LIHs but not with MIH.
These findings, including the results of our study, sup-
port the notion that different pathophysiological mecha-
nisms are involved in MIH and LIH, which must be taken
into account when selecting the most appropriate technique
and implant for inguinal hernia surgery. This study
strengthens the idea that resorbable meshes are not enough
to prevent recurrences in patients with MIH.
Pain
The performance parameters investigated in this study
show promising results in terms of pain and foreign body
sensation. Both these parameters were constantly declining
during the course of the follow-up period, reaching low
levels after 1 year.
In the clinical literature, there is a remarkable spread in
the data concerning the risk of pain and discomfort after
inguinal hernia surgery (20–45 %) as well as follow-up
methods [1, 32]. The ambiguous preexisting data, com-
bined with the subjectivity of pain measurements, leaves
any comparison between different studies of low scientific
value at this point. Even when taking into account that
patients with preexisting pain conditions unrelated to the
hernia were excluded, the results of this study on chronic
pain (0 % in the VAS-form, 7 % in the IPQ-form) and
mesh sensation (0 %) in patients with LIH at the 3-year
follow-up are so good that it opens the door for larger,
randomized studies to confirm these findings.
Considering the finding that the mesh was 100 % re-
sorbed at the 3-year follow-up, it is also interesting to
further investigate the origin of the pain that a proportion of
the patients still can feel in certain situations. Another
intriguing finding is the mesh sensation that remains in a
small subset of the patients after the mesh itself has been
resorbed completely. We leave it to future trials to inves-
tigate the potential of the long-term resorbable mesh
Table 6 Factors related to patient quality of life following surgery at 6, 12 and 36 months
6 months (n = 38) 12 months (n = 38) 36 months (n = 31)
Yes No Yes No Yes No
Normal sensation in the groin 24 (63.2) 14 (36.8) 31 (81.6) 7 (18.4) 25 (80.6) 6 (19.4)
Can feel a mesh in the groin 7 (18.4) 30 (81.6) 4 (10.5) 34 (89.5) 3 (9.7) 28 (90.3)
Values in parenthesis are percentages calculated from the number of subjects with available data at respective visit
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concept in terms of reduction of chronic postoperative pain
after LIH repair, as it was not the primary objective for this
study.
Conclusion
The use of a synthetic long-term resorbable mesh (TIGR
Matrix Surgical Mesh) in Lichtenstein repair was found to
be safe, without recurrence, and promising regarding pain/
discomfort at the 3-year follow-up in patients with LIH.
However, patients with MIH and CIH had high recurrence
rates.
The definitive role of long-term degradable implants to
reduce the risk of chronic postoperative pain after inguinal
hernia repair for lateral hernias must be investigated in
larger randomized studies.
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